Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Nkarta, Inc.
Nkarta, Inc. is a South San Francisco, California-based company founded in 2015.
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 15 Jan, 2024
"NL fact extraction"
Golden Au
edited on 15 Jan, 2024
Edits made to:
Infobox
(
+2
properties)
Infobox
Founded Date
2015
0
Number of Employees (Ranges)
51 – 200
0
Edits on 16 Oct, 2022
Оля Рашина
edited on 16 Oct, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Fax Number
415-582-4923
0
Оля Рашина
edited on 16 Oct, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Full Address
Nkarta, Inc. 6000 Shoreline Court Suite 102 South San Francisco CA 94080
0
Оля Рашина
edited on 16 Oct, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
LinkedIn URL
https://www.linkedin.com/company/nkarta-therapeutics-inc/
Оля Рашина
edited on 16 Oct, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Email Address
info@nkartatx.com
0
Edits on 30 Aug, 2022
"Edit from table cell"
Dhruv Sharma
edited on 30 Aug, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Official Website
https://www.nkartatx.com/
Edits on 10 Jun, 2022
"Entity importer update"
Golden AI
edited on 10 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Is a
Organization
Edits on 8 Apr, 2022
"Patent autocalculation"
Golden AI
edited on 8 Apr, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents assigned (count)
3
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-2
properties)
Infobox
Patents
US Patent 11141436 Immune cells engineered to express CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
US Patent 11154575 Cancer immunotherapy using CD19-directed chimeric antigen receptors
Edits on 27 Oct, 2021
Golden AI
edited on 27 Oct, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents
US Patent 11154575 Cancer immunotherapy using CD19-directed chimeric antigen receptors
Edits on 13 Oct, 2021
Golden AI
edited on 13 Oct, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents
US Patent 11141436 Immune cells engineered to express CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
Edits on 23 Jul, 2021
"Funding autocalculation"
Golden AI
edited on 23 Jul, 2021
Edits made to:
Infobox
(
+3
/
-2
properties)
Infobox
Latest funding round date
August 2019
Total funding amount (USD)
114,636,678
Latest funding round date
September 4, 2019
Latest funding type
Series B Round
Total funding amount (USD)
228,636,678
Golden AI
edited on 23 Jul, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding rounds
Nkarta, Inc. Series B round, September 2019
Edits on 6 Oct, 2020
"Funding autocalculation"
Golden AI
edited on 6 Oct, 2020
Edits made to:
Infobox
(
+1
properties)
Infobox
Latest funding round date
August 2019
Edits on 17 Jul, 2020
"Funding autocalculation"
Golden AI
edited on 17 Jul, 2020
Edits made to:
Infobox
(
+1
properties)
Infobox
Total funding amount (USD)
114,636,678
Edits on 6 Sep, 2019
Golden AI
edited on 6 Sep, 2019
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding rounds
Nkarta, Inc. funding round, August 2019
Golden AI
edited on 6 Sep, 2019
Edits made to:
Infobox
(
+5
properties)
Infobox
Is a
Company
Location
South San Francisco, California
Legal classification
Corporation
CIK number
1,787,400
Place of incorporation
Delaware
"Initial topic creation"
Golden AI
created this topic on 6 Sep, 2019
Edits made to:
Nkarta, Inc.
Find more companies like Nkarta, Inc.
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE